42
Participants
Start Date
December 31, 2006
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2010
oxaliplatin
"Group I: Patients receive pemetrexed disodium IV and oxaliplatin IV over 2 hours on day 1. Treatment repeats every 14 days for up to 4 courses. If patient progresses before receiving 4 courses of treatment, treatment will be discontinued and patient will proceed to surgery.~Group II: Patients receive treatment as in group I. If patient progresses before receiving 4 courses of treatment, treatment will be discontinued and patient will proceed to concurrent chemoradiotherapy."
pemetrexed disodium
"Group I: Patients receive pemetrexed disodium IV and oxaliplatin IV over 2 hours on day 1. Treatment repeats every 14 days for up to 4 courses. If patient progresses before receiving 4 courses of treatment, treatment will be discontinued and patient will proceed to surgery.~Group II: Patients receive treatment as in group I. If patient progresses before receiving 4 courses of treatment, treatment will be discontinued and patient will proceed to concurrent chemoradiotherapy."
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
Vanderbilt-Ingram Cancer Center at Franklin, Nashville
MBCCOP - Meharry Medical College - Nashville, Nashville
West Tennessee Cancer Center at Jackson-Madison County General Hospital, Jackson
Purchase Cancer Group - Paducah, Paducah
Mitchell Memorial Cancer Center at Owensboro Medical Health System, Owensboro
Vanderbilt-Ingram Cancer Center, Nashville
National Cancer Institute (NCI)
NIH
Vanderbilt-Ingram Cancer Center
OTHER